Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Press Releases

  • 10/19/2010

    Hear from the FDA, National Institute of Health and More at PDA Freeze Drying Workshop

    Hear from the US FDA, National Institute of Health and More at PDA’s 2010 Pharmaceutical Freeze Drying Workshop
  • 03/13/2011

    PDA is pleased to announce the launch of a new web site (www.pda.org)

    PDA is working on improving member engagement and their satisfaction is at the forefront of our decision to invest in a new web site with enhanced navigation.
  • 06/07/2011

    PIC/S Celebrates 40th Anniversary

    US FDA Commissioner, Dr. Margaret Hamburg, calls for closer and more global cooperation on GMP at PIC/S 40th Anniversary
  • 06/05/2011

    First-time event on glass quality by PDA a success

    PDA along with the US FDA hosted the 2011 PDA/FDA Glass Quality Conference & TRI Courses on May 23-26, 2011 in Arlington, Virginia. “The first-time event had great content and participation [and]...brought to the table the most relevant topics,” said Richard M. Johnson, PDA President.
  • 08/07/2011

    Deborah Autor, Deputy Commissioner for Global Regulatory Operations and Policy to Give Opening Keyno

    Bethesda, Md., August 8, 2011 – The Parenteral Drug Association (PDA) is proud to announce that Deborah Autor, Deputy Commissioner for Global Regulatory Operations and Policy will give the Opening Keynote speaker at the 2011 PDA/FDA Joint Regulatory Conference & TRI Courses, Sept. 19-21, Renaissance Washington Hotel in Washington, D.C.
  • 09/07/2011

    The Parenteral Drug Association Announces Timely Updates to its Membership Structure

    Bethesda, Md., September 7, 2011 – The Parenteral Drug Association (PDA) is pleased to announce new measures enhancing the availability of PDA membership including an expanded Emerging Economy membership, a new option for Retired Membership, and additional assistance for members who are currently seeking employment in the Pharmaceutical industry.
  • 04/22/2012

    PDA Announces a Landmark Workshop on QbD

    The Parenteral Drug Association (PDA) is coordinating a critical discussion on the implementation of QbD concepts in vaccine development.Five vaccine manufacturers (GlaxoSmithKline, MedImmune, Merck, Pfizer and Sanofi Pasteur) have joined to form the CMC-VWG, with assistance from PricewaterhouseCoopers, to create a case study describing the development of the fictitious vaccine A-Vax. The goal of the workshop is to initiate a discussion of the case study and to provide a review of the QbD approaches employed for the development of A-Vax.
  • 09/06/2012

    PDA’s 2012 Universe of Pre-filled Syringes & Injection Devices - the Best Mindshare in the Industry

    Our industry is entering a challenging phase for the next decade in the area of pre-filled syringes & injection devices. Costs and regulatory demands exert downward pressure on our ability to introduce devices that are safe and effective. Patients and their needs continue to grow while ever more complex molecules continue to challenge our material selection. Regulatory requirements, industry experience and evolving market trends are critical considerations to ensure a complete understanding of the application of pre-filled syringes and injection devices to drug delivery.
  • 09/20/2012

    PDA Announces New Technical Report (TR) Portal by the End of 2012

    “This is the most innovative and significant member benefit ever offered by The Parenteral Drug Association (PDA),” said Richard M. Johnson, PDA President. “We have been working hard on enhancing our member value and we believe that releasing this new Technical Report Portal by the end of 2012 is a breakthrough benefit that you just don’t see anywhere.
  • 10/31/2012

    PDA Announces Establishment of New Chapter in India

    Bethesda, Md., October 31, 2012 – The Parenteral Drug Association (PDA) is proud to announce the founding of the PDA India Chapter, which will serve PDA members in India.
  • 12/09/2012

    PDA’s New Technical Report Portal is Now Open!

    PDA Technical Reports are highly valued, global technical documents prepared by member-driven Task Forces comprised of content experts, including scientists and engineers working in the pharmaceutical and biopharmaceutical industry, regulatory authorities and academia.
  • 01/06/2013

    PDA Establishes the Martin VanTrieste Pharmaceutical Science Award

    Bethesda, Md., January 7, 2013 – The Parenteral Drug Association (PDA) is proud to announce the establishment of the Martin VanTrieste Pharmaceutical Science Award.
  • 08/18/2013

    INTERPHEX and PDA Announce Agreement

    NORWALK, CT, Aug. 19, 2013 – International Pharmaceutical Expo (INTERPHEX), the leading annual trade event dedicated to the pharmaceutical and biopharmaceutical industry and the Parenteral Drug Association (PDA) are pleased to announce a three-year Sponsorship Agreement.
  • 12/17/2012

    PDA Announces the Results of the 2013 Board of Directors and Officers Election

    PDA is pleased to announce the results of the 2013 Board of Directors and Officers election. The elected candidates will fill their term beginning on January 1, 2012. Thank you to all who voted!
  • 02/21/2013

    FDA’s Rick Friedman and Rebecca Rodriguez Confirmed as Closing Plenary Speakers for PDA Human Factors Workshop

    PDA announced today that Richard Friedman, Associate Director OMPQ, U.S. FDA, and Rebecca Rodriguez, Consumer Safety Officer, U.S. FDA, have been confirmed to deliver the closing plenary talks at the 2013 Human Factors and Human Error Reduction Workshop.
  • 01/31/2013

    PDA Announces Establishment of New Chapter in Texas

    Bethesda, Md., February 1, 2012 – The Parenteral Drug Association (PDA) is proud to announce the founding of the PDA Texas Chapter, which will serve PDA members in that area.
  • 07/16/2012

    PDA Pres. Signs Landmark Agreement with The St. Petersburg’s State Chemical Pharm. Academy (SPCPA)

    Bethesda, Md., July 16, 2012 – St Petersburg, Russia (June 22, 2012) – The Parenteral Drug Association (PDA) and The Saint-Petersburg State Chemical-Pharmaceutical Academy (SPCPA) have signed a Memorandum of Understanding to develop a GMP and Regulatory Affairs Training Center in the area of pharmaceutical manufacturing in St. Petersburg (the Training Center).
12345678